SpadeRx provides access to compounded medications for qualified patients. Compounded medications are not FDA-approved and may differ in risks, benefits, and side effects compared to FDA-approved products. A licensed provider will perform a telehealth Good Faith Exam (GFE) to determine patient eligibility before any prescription is issued. Not all patients are candidates, and individual results may vary. Novo Nordisk Inc. and Eli Lilly and Company are the only U.S. manufacturers of FDA-approved semaglutide (Rybelsus®, Ozempic®, Wegovy®) and tirzepatide (Zepbound®, Mounjaro®), respectively. These manufacturers do not supply their medications for compounding.